Navigation Links


Clintrax Global, Inc. Announces Addition to Executive Team

8/20/2014
RALEIGH, N.C. , Aug. 20, 2014 Clintrax Global, Inc., a worldwide provider of clinical research services located in Raleigh, NC , recently announced the addition of Bradford Evans as Vice President of Administration. As Vice President of Administration, Brad will oversee all corporate processes, including their alignment with company objectives and policies.  Prior... [Comments]

Early bottlenecks in developing biopharmaceutical products delay commercialization

8/20/2014
An analysis of patented university inventions licensed to biotechnology firms has revealed early bottlenecks on the path to commercialization. To open these roadblocks, the researchers suggest that better communication of basic research results during the discovery stage could lead to faster co... [Comments]Early bottlenecks in developing biopharmaceutical products delay commercialization

Unusual discovery leads to fascinating tuberculosis theory

8/20/2014
Grade school history lessons often have it that American Indians largely were wiped out by diseases such as whooping cough, chicken pox, influenza and tuberculosis brought to the New World by European explorers. One report says, while estimates vary, about 20 million people lived in the Americas shortly before Europeans arrived, and roughly 95 percent of them were killed by European diseases.... [Comments]

Seeing a molecule breathe

8/20/2014
For the first time, chemists have succeeded in measuring vibrational motion of a single molecule with a femtosecond time resolution. The study reveals how vibration of a single molecule differs from the behaviour of larger molecular groups. The study was performed at the University of California, Irvine, where post-doctoral researcher Eero Hulkko from the University of Jyvskyl works as... [Comments]

Neurotrope To Host Conference Call

8/20/2014
PLANTATION, Fla. , Aug. 20, 2014 Neurotrope, Inc. (OTCQB: NTRP) today announced that it will host a conference call to provide an update on Company activities. Access information:Date:Tuesday, August 26, 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or (719) 325-2315 Conference ID number: 9126599 Live web cast: www.neurotropebioscienc... [Comments]

New Project Is the ACME of Addressing Climate Change

8/20/2014
Livermore, California (PRWEB) August 20, 2014 High performance computing (HPC) will be used to develop and apply the most complete climate and Earth system model to address the most challenging and demanding climate change issues. Eight national laboratories, including Lawrence Livermore , are combining forces with the National Center for Atmospheric Research, four academic institutions... [Comments]

BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market

8/20/2014
BURLINGTON, Mass. , Aug. 20, 2014  Decision Resources Group finds that the vascular access device market in Brazil , Russia , India and China (BRIC) was valued at approximately $1.6 billion in 2013, roughly equal to the size of the United States market that year. Going forward, however, the BRIC market will experience much faster growth as a result of str... [Comments]

PAREXEL International To Present At Baird Healthcare Conference

8/20/2014
BOSTON , Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: PRXL ) announced today that it will be presenting at the Baird Healthcare Conference in New York.  Ingo Bank , Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 4:40 p.m. EDT on Wednesday, Sept. 3, 2014. A live webca... [Comments]

6th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing

8/20/2014
San Francisco, CA (PRWEB) August 20, 2014 The 6th Annual Arrowhead Personalized and Precision Medicine Conference is being held on October 29-30 in San Francisco, CA. This year’s conference brings together fresh perspectives from industry, academic and government researchers and clinicians focused on addressing and solving the significant hurdles remaining in the space. In the twelve... [Comments]

Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks

8/20/2014
Toronto, Canada (PRWEB) August 20, 2014 Not long ago, it was more or less conventional wisdom that E&L studies should be performed late in the development cycle – even after the final container/closure system is known. But current regulatory trends suggest that, like many things GxP, expectations for early E&L data are on the rise. In recent years, multiple drug sponsors have been r... [Comments]

[next]
(Date:8/20/2014)... life can persist in a cold, dark world. A ... that examined waters and sediments from a shallow lake ... extreme environment supports microbial ecosystems. , The National ... has implications for life in other extreme environments, both ... are published in the current edition of the science ...
(Date:8/20/2014)... State University, the Wellcome Trust Sanger Institute and the ... Mycobacterium pinnipedii from skeletons found in Peru ... is a relative of the TB bacterium that affects ... These researchers assume that seals carried the pathogens from ... lions was unexpected" comments Sebastien Gagneux, from the Swiss ...
(Date:8/20/2014)... screening outcomes of approximately 3 million infants, a team ... the University of Massachusetts Medical School, have shown that ... successfully implemented across public health newborn screening programs. Data ... 20 issue of the Journal of the American ... of SCID in newborns is higher than previously thought ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3
... wily coyote reigns as top dog in much of the ... its larger relative, the wolf, according to a new study ... more than 30 percent lower in areas that they share ... edition of the Journal of Animal Ecology, details the results ...
... UCSF scientists are reporting what they say is a ... cells to their embryonic state, a process that transforms ... The finding, published on-line as an immediate early publication ... the strategic breakthrough reported by Shinya Yamanaka, MD, PhD, ...
... complex behaviour of primates can be understood using artificially-intelligent ... published in a special edition of Philosophical Transactions of ... Festival of Science in York. Scientists using ... some primate groups are despotic whilst others are egalitarian ...
Cached Biology News:Who's afraid of the big, bad wolf? Coyotes 2Embryonic stem cell strategy advanced with UCSF finding 2Embryonic stem cell strategy advanced with UCSF finding 3Embryonic stem cell strategy advanced with UCSF finding 4Primate behavior explained by computer 'agents' 2
... were designed for full-length gene cloning and ... identify the desired cDNA clone. The first ... "Master Plate," where each well contains plasmid ... positive well(s) by gel electrophoresis of the ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... Maxi Kit provides a fast and simple procedure ... for buffer exchange, and for removing different types ... based on spin-column chromatography using Norgens patented protein ... MgCl 2 , NaCl, KCl, CaCl 2 , ...
... variant: With the macro- ... by Hoagland and Arnon ... Formulated to contain 1.6 ... per liter of medium. ...
Biology Products:
(Date:8/20/2014)... Aug. 20, 2014 Clintrax Global, Inc., ... in Raleigh, NC , recently ... as Vice President of Administration. ... all corporate processes, including their alignment with company ... Brad worked as an HR executive, specializing in ...
(Date:8/20/2014)... of patented university inventions licensed to biotechnology firms ... commercialization. To open these roadblocks, the researchers suggest ... the discovery stage could lead to faster commercialization ... derived from discoveries made in university laboratories and ... during clinical trials, which have a high failure ...
(Date:8/20/2014)... school history lessons often have it that American Indians ... cough, chicken pox, influenza and tuberculosis brought to the ... estimates vary, about 20 million people lived in the ... of them were killed by European diseases., But new ... State University and Johannes Krause of the University of ...
(Date:8/20/2014)... in measuring vibrational motion of a single molecule with ... of a single molecule differs from the behaviour of ... at the University of California, Irvine, where post-doctoral researcher ... a visiting fellow under professor Vartkess A. Apkarian, whose ... lead by Professor Eric O. Potma. The results of ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Seeing a molecule breathe 2
... EL SEGUNDO, Calif., July 27 NASA has exercised a ... continuing support to the Space Life Sciences Directorate at NASA,s Johnson ... The work will be done by Wyle,s Integrated Science and ... the bioastronautics contract, Wyle,s work supports the International Space Station, space ...
... , , , , ... Cardium Therapeutics (NYSE Amex: CXM ) ("Cardium") reported that ... that it had now resolved matters relating to the company,s exchange ... , In the communication from NYSE Amex, Cardium ...
... , , ... Pharmaceuticals, Inc. (NYSE-AMEX: NBY ) ( http://www.novabaypharma.com ), ... treatment or prevention of a wide range of bacterial, viral ... and Chief Executive Officer, will present at the Jesup & ...
Cached Biology Technology:NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million 2Cardium Regains Listing Compliance with NYSE Amex 2Cardium Regains Listing Compliance with NYSE Amex 3NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 2NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 3